Meet with ASX-listed, Pre-IPO and Startup companies at lunches and networking events - matched to your investment interests and city. Open to retail and professional investors.
How it works
Tell us your city and the sectors you invest in. Takes under a minute.
We match upcoming lunches to your profile and send an invitation by email.
Meet company management over lunch - in person or online, usually at no cost.
Sectors we cover
Critical minerals for the energy shift. Fintech for global trade. Biotech for better health. Whatever matters to you - we'll prioritise the invitations you get.
Upcoming events
We launched just a few weeks ago and are progressively adding events as we grow. Help us grow by forwarding this website link to a friend.
Pitch your story directly to a curated audience of investors, in person or online.
EnquireNova Eye Medical is a pioneering medical technology company dedicated to advancing the treatment of glaucoma across the full patient journey. Grounded in close collaboration with leading ophthalmic surgeons worldwide, the company designs, develops, and commercialises innovative surgical solutions shaped by real-world clinical practice. Their core philosophy centers on providing intuitive, tissue-preserving, and physiological options that seamlessly integrate into the surgical workflow while optimizing patient outcomes. At the forefront of Nova Eye’s product portfolio is the iTrack™ Advance, an illuminated microcatheter featuring an ergonomic handpiece engineered to support angle-based minimally invasive glaucoma surgery (MIGS) and canaloplasty. Building upon the proven track record of the original iTrack™ system, which has been used in more than 150,000 procedures globally, the platform allows surgeons to precisely catheterise and viscodilate Schlemm's canal. For more severe and complex glaucoma cases, the company also offers the Molteno3® drainage device, ensuring clinicians are equipped across the spectrum of disease severity. What truly distinguishes Nova Eye in the ophthalmic landscape is its strong commitment to restoring natural, physiological outflow without the need for permanent stent implants or unnecessary tissue destruction. Innovations such as their proprietary Shear Clear™ technology further refine procedures by optimising viscoelastic delivery during canaloplasty. Backed by a prominent network of global surgeon partners and regular presentations at major international congresses, Nova Eye continues to drive the mainstream adoption of interventional glaucoma, empowering physicians to deliver safer, highly repeatable, and effective care.
Join the mailing list to be notified as soon as new lunches go live.
Join the list
How we host
Invite-only lunches at restaurants and private function rooms in your capital city. Small groups, direct access to company management, real conversation after the presentation.
Bring investors from every city into one room. A Perth-based company can reach east coast investors without booking a multi-city roadshow. At the host's discretion, we'll send an Uber Eats voucher as a thank-you for tuning in.
Selected lunches are recorded and made available to registered investors online, so missing the date doesn't mean missing the opportunity. Availability varies by event - your invitation will note if a replay is offered.
